Barrow, Hanley, Mewhinney & Strauss
AHCO icon

Barrow, Hanley, Mewhinney & Strauss’s AdaptHealth AHCO Stock Holding History

Barrow, Hanley, Mewhinney & Strauss’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-69
Closed -$687 – 378
2025
Q4 		$687 Hold
69
– – ﹤0.01% 345
2025
Q3 		$618 Buy
+69
New +$639 ﹤0.01% 341

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss's AHCO Position: Q1 2026 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of AdaptHealth (AHCO) in Q1 2026, closing a stake of 69 shares — an estimated $687 sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in AHCO in Q3 2025 and held it in 2 quarters. The position peaked at $687 in Q4 2025. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Barrow, Hanley, Mewhinney & Strauss reported no remaining AdaptHealth position as of Q1 2026 after selling out during the quarter.
  • Barrow, Hanley, Mewhinney & Strauss sold 69 AdaptHealth shares in Q1 2026, an estimated $687.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in AdaptHealth in Q3 2025 and held it in 2 quarters.
  • Barrow, Hanley, Mewhinney & Strauss's AdaptHealth position peaked at $687 in Q4 2025.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q1 2026, filed 13 May 2026.